Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KitazatoTSE:368A +0.79%22 ROA % is 19.97% as of Mar. 2026, which is 5% below its 10-year median of 20.95. GuruFocus rates TSE:368A with a GF Score™ of 22/100. Among 854 Medical Devices & Instruments companies, Kitazato ranks better than 96.84% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Kitazato's annualizedNet Income for the quarter that ended in Mar. 2026 was 円4,182 Mil.
Kitazato's average Total Assets over the quarter that ended in Mar. 2026 was 円20,946 Mil. Therefore, Kitazato's annualized ROA % for the quarter that ended in Mar. 2026 was 19.97%.
The historical rank and industry rank for Kitazato's ROA % or its related term are showing as below:
TSE:368A'
s ROA % Range Over the Past 10 Years
Min: 18.66 Med: 20.95 Max: 23.81
Current: 18.96
During the past 4 years, Kitazato's highest ROA % was 23.81%. The lowest was 18.66%. And the median was 20.95%.
TSE:368A's ROA % is ranked better than 96.84% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 0.575
vs TSE:368A: 18.96
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is two times the semi-annual (Mar. 2026) net income data. The Revenue data used here is two times the semi-annual (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Kitazato ROA % Related Terms
Kitazato ROA % Historical Data
* Premium members only.
The historical data trend for Kitazato's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Kitazato's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kitazato ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Kitazato's ROA % distribution charts can be found below:
* The bar in red indicates where Kitazato's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Kitazato (TSE:368A) has a ROA % of 19.97% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Kitazato and its competitors. This is near median its historical median of 20.95. Over the past decade, Kitazato's ROA % has ranged from 18.66 to 23.81. According to the industry distribution chart, Kitazato ranks #27 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 3.2%.
Is Kitazato's ROA % too high?
Kitazato's current ROA % of 19.97% is near median its 10-year median of 20.95. Over the past 10 years, this metric has ranged from a low of 18.66 to a high of 23.81. The Medical Devices & Instruments industry median ROA % is 0.58. Kitazato's value of 19.97% is 3373% above this industry median. Based on the distribution chart, Kitazato ranks #27 out of 854 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Kitazato has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Kitazato's ROA % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Kitazato ranks #27 out of 854 companies for ROA %. This places Kitazato in the top 3% of its industry — outperforming the majority of peers. The industry median ROA % is 0.58. Kitazato's value of 19.97% is 3373% above this benchmark. Historically, Kitazato's own ROA % has ranged from 18.66 to 23.81 over the past decade. While the company's 10-year median is 20.95 vs. the industry median of 0.58, Kitazato has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.58, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kitazato's current ROA % of 19.97% is 3373% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Kitazato and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kitazato's current ROA % is 19.97%, which is near median its own 10-year median of 20.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kitazato stock overvalued right now?
Kitazato (TSE:368A) has a current ROA % of 19.97%. The current ROA % is 19.97%, which is near median its 10-year median of 20.95 and 3373% above the Medical Devices & Instruments industry median of 0.58. Kitazato's overall GF Score™ is 22/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Kitazato (TSE:368A), the current ROA % is 19.97% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kitazato Corp is engaged in manufacture and sale of medical devices and related products for fertility treatment. Its products include Needles, Catheters and Cannulas, Vitrification Media and Equipments, Sperm Processing Medium/Tools, IVF Medium, etc.
22GF Score
Get the complete analysis for TSE:368A
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:368A has been successfully added to your 
